These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33191408)

  • 1. A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer.
    Kang JH; Lee KH; Kim DW; Kim SW; Kim HR; Kim JH; Choi JH; An HJ; Kim JS; Jang JS; Kim BS; Kim HT
    Br J Cancer; 2021 Feb; 124(4):713-720. PubMed ID: 33191408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs.
    Park YH; Chung CU; Park BM; Park MR; Park DI; Moon JY; Park HS; Kim JH; Jung SS; Kim JO; Kim SY; Lee JE
    Can Respir J; 2016; 2016():3576201. PubMed ID: 28018128
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients.
    Kim GM; Kim YS; Ae Kang Y; Jeong JH; Kim SM; Hong YK; Sung JH; Lim ST; Kim JH; Kim SK; Cho BC
    J Thorac Oncol; 2012 Apr; 7(4):731-6. PubMed ID: 22425922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer.
    Kim HS; Park SY; Park CY; Kim YT; Kim BJ; Song YJ; Kim BG; Kim YB; Cho CH; Kim JH; Song YS
    Br J Cancer; 2021 Jan; 124(2):375-382. PubMed ID: 32994466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancer.
    Spigel DR; Greco FA; Burris HA; Shipley DL; Clark BL; Whorf RC; Arrowsmith ER; Hainsworth JD
    Clin Lung Cancer; 2011 May; 12(3):187-91. PubMed ID: 21663862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy between topotecan- and belotecan-, a new camptothecin analog, based chemotherapies for recurrent epithelial ovarian cancer: a single institutional experience.
    Kim HS; Park NH; Kang S; Seo SS; Chung HH; Kim JW; Song YS; Kang SB
    J Obstet Gynaecol Res; 2010 Feb; 36(1):86-93. PubMed ID: 20178532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer.
    Yeo CD; Lee SH; Kim JS; Kim SJ; Kim SC; Kim YK; Kang HH; Yoon HK; Song JS; Moon HS; Kim JW; Kim KH; Shim BY; Kim CH
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):809-14. PubMed ID: 23918044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
    Goto K; Ohe Y; Shibata T; Seto T; Takahashi T; Nakagawa K; Tanaka H; Takeda K; Nishio M; Mori K; Satouchi M; Hida T; Yoshimura N; Kozuki T; Imamura F; Kiura K; Okamoto H; Sawa T; Tamura T;
    Lancet Oncol; 2016 Aug; 17(8):1147-1157. PubMed ID: 27312053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer.
    Rhee CK; Lee SH; Kim JS; Kim SJ; Kim SC; Kim YK; Kang HH; Yoon HK; Song JS; Moon HS; Kim JW; Kim CH; Shim BY; Kim HK; Sun DS; Kim KH
    Lung Cancer; 2011 Apr; 72(1):64-7. PubMed ID: 20832894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
    Spigel DR; Dowlati A; Chen Y; Navarro A; Yang JC; Stojanovic G; Jove M; Rich P; Andric ZG; Wu YL; Rudin CM; Chen H; Zhang L; Yeung S; Benzaghou F; Paz-Ares L; Bunn PA;
    J Clin Oncol; 2024 Jul; 42(19):2317-2326. PubMed ID: 38648575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease.
    Enomoto Y; Inui N; Imokawa S; Karayama M; Hasegawa H; Ozawa Y; Matsui T; Yokomura K; Suda T
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):499-505. PubMed ID: 26134440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.
    Imai H; Yamada Y; Minemura H; Sugiyama T; Kotake M; Kaira K; Kanazawa K; Nakamura Y; Kasai T; Shibata Y; Kaburagi T; Minato K;
    Thorac Cancer; 2018 Dec; 9(12):1699-1706. PubMed ID: 30281216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
    Baize N; Monnet I; Greillier L; Geier M; Lena H; Janicot H; Vergnenegre A; Crequit J; Lamy R; Auliac JB; Letreut J; Le Caer H; Gervais R; Dansin E; Madroszyk A; Renault PA; Le Garff G; Falchero L; Berard H; Schott R; Saulnier P; Chouaid C;
    Lancet Oncol; 2020 Sep; 21(9):1224-1233. PubMed ID: 32888454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter phase II study of belotecan, new camptothecin analogue, in patients with previously untreated extensive stage disease small cell lung cancer.
    Kim SJ; Kim JS; Kim SC; Kim YK; Kim YK; Kang JY; Yoon HK; Song JS; Lee SH; Moon HS; Kim JW; Kim KH; Kim CH; Shim BY; Kim HK
    Lung Cancer; 2010 Jun; 68(3):446-9. PubMed ID: 19683359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial.
    Jeong J; Cho BC; Sohn JH; Choi HJ; Kim SH; Lee YJ; Jung MK; Shin SJ; Park MS; Kim SK; Chang J; Kim JH
    Lung Cancer; 2010 Oct; 70(1):77-81. PubMed ID: 20138389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer.
    Edelman MJ; Dvorkin M; Laktionov K; Navarro A; Juan-Vidal O; Kozlov V; Golden G; Jordan O; Deng CQ; Bentsion D; Chouaid C; Dechev H; Dowlati A; Fernández Núñez N; Ivashchuk O; Kiladze I; Kortua T; Leighl N; Luft A; Makharadze T; Min Y; Quantin X;
    Lung Cancer; 2022 Apr; 166():135-142. PubMed ID: 35278766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer.
    Lv C; Liu X; Zheng Q; Chen H; Yang X; Zhong J; Wang Y; Duan J; Wang Z; Bai H; Wu M; Zhao J; Wang J; Wang Z; An T; Zhuo M
    Thorac Cancer; 2018 Sep; 9(9):1166-1173. PubMed ID: 30058109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
    Chiappori AA; Otterson GA; Dowlati A; Traynor AM; Horn L; Owonikoko TK; Ross HJ; Hann CL; Abu Hejleh T; Nieva J; Zhao X; Schell M; Sullivan DM
    Oncologist; 2016 Oct; 21(10):1163-1164. PubMed ID: 27694157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer.
    Wakuda K; Kenmotsu H; Naito T; Akamatsu H; Ono A; Shukuya T; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Endo M; Nakajima T; Yamamoto N
    Am J Clin Oncol; 2015 Feb; 38(1):28-32. PubMed ID: 23388567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral topotecan and bevacizumab combination as second-line treatment for relapsed small-cell lung cancer: an open-label multicenter single-arm phase II study.
    Spigel DR; Waterhouse DM; Lane S; Legenne P; Bhatt K
    Clin Lung Cancer; 2013 Jul; 14(4):356-63. PubMed ID: 23391616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.